34 results
8-K
EX-1.1
TEVA
Teva- Pharmaceutical Industries Ltd.
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm
) and the Guarantor, jointly and severally, agree to pay:
(a) the costs incident to the authorization, issuance, sale and delivery of the Securities … , and any taxes payable in that connection;
(b) the costs incident to the preparation, printing and distribution of the Prospectus and any amendment
424B5
Teva Pharmaceutical Finance Netherlands II B.V.
4 Nov 21
Prospectus supplement for primary offering
4:41pm
negative incident could significantly affect our reputation and damage our business. We may be adversely affected by any negative publicity, regardless
424B3
Teva Pharmaceutical Finance Netherlands II B.V.
27 Oct 21
Prospectus supplement
8:51am
. Any negative incident could significantly affect our reputation and damage our business. We may be adversely affected by any negative publicity
424B3
14r twz73n
17 Aug 20
Prospectus supplement
9:12am
8-K
EX-4.4
f54fo
25 Nov 19
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-4.8
xyx3fkb2k02q8x3po
25 Nov 19
Entry into a Material Definitive Agreement
5:01pm
424B3
6lk6bqsm209k id
19 Apr 18
Prospectus supplement
12:00am
6-K
EX-1.1
1a2tddm9ddn 8p
18 Dec 12
Current report (foreign)
12:00am
6-K
EX-1.2
4xfi0v
18 Dec 12
Current report (foreign)
12:00am
6-K
EX-1.1
cexvgofcq980l
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.3
ay2r uwvmb3l
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.2
aq6gk4x0vfon
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-2.1
9d3ckolahrd
28 Jul 11
Current report (foreign)
12:00am
6-K
EX-1.1
y43bixrxo aw4o5n4cs
21 Mar 11
Current report (foreign)
12:00am
6-K
EX-1.2
m1if8z128506k v7
18 Jun 10
Current report (foreign)
12:00am